About Us

Membership

Accomplishments

Meetings

Support

Newsroom

SITC News

Society and Member News | E-newsletters | Press Releases | For the Media

Press Releases

2011

Researchers Honored at the Society for Immunotherapy of Cancer 26th Annual Meeting Awards Ceremony
(November 7, 2011)
New research on immune based therapies for cancer presented at the SITC 26th Annual Meeting & Associated Programs (November 5, 2011)
Nobel Laureates Scheduled to Present at the SITC Annual Meeting (October 5, 2011)
FDA Approves Ipilimumab, Major Breakthrough in Cancer Immunotherapy (March 25, 2011)

2010

NIH Awards Major Funding to Support "Cancer Immunotherapy Trials Network" (October 4, 2010)
Leading Cancer Immunotherapy Scientists and Research Teams Honored at iSBTc Annual Meeting (October 4, 2010)
Major Advances in Cancer Immunotherapy Highlighted at Key Scientific Meetings in Washington, D.C. (September 23, 2010)
Cancer Immunotherapies Coming of Age (June 8, 2010)
Immunotherapy Breakthrough for Cancer Patient Treatment (June 6, 2010)
FDA Approval of New Prostate Treatment Shows Promise of Cancer Immunotherapy (April 29, 2010)

2009

iSBTc 2009 Annual Meeting Profiled in Oncology Times (December 10, 2009)
More Hope for Cancer Victims: iSBTc Presents the Promise of Immunotherapy & Biological Therapy (October 22, 2009)
Dr. Isaiah J. Fidler to Receive 2009 iSBTc Richard V. Smalley, MD Memorial Award (October 12, 2009)
More Promise for Immunotherapy: Dendreon's Provenge® Meets Primary Endpoint (April 14, 2009)

2008

Global Regulatory Summit Focuses on Oncology Biologics Product Development (November 24, 2008)
iSBTc Hosts Educational Programs Addressing Cancer and Inflammation; Tumor Immunology (November 20, 2008)
The Future/Fate of Agents Targeting CTLA4: A "Hot Topic" at the iSBTc Annual Meeting (November 18, 2008)
International Cancer Researchers Gather to Discuss Immunology/Biological Therapy at iSBTc (November 17, 2008)
iSBTc Meeting Features Newest Data in Cancer Immunotherapy, Biological Therapy (October 27, 2008)
iSBTc Workshop to Address Cancer and Inflammation (October 24, 2008)
Cancer Leaders to Address Tumor Immunology and Biological Therapy (October 24, 2008)
iSBTc to Host Global Regulatory Summit on Oncology Biologics Product Development (October 20, 2008)
iSBTc Annual Meeting to Highlight Latest Advances in Cancer Immunotherapy (October 21, 2008)
iSBTc Primer Provides Guidance on Regulatory Expectations, Strategies for Oncology Biologics Development in the US, EU and Japan (March 21, 2008)

2007

NCI Immunotherapy Workshop Develops Ranked List of Agents with High Potential
for Use in Treating Cancer (November 16, 2007)
Debate Over Dendreon's Provenge Discussed at iSBTc Annual Meeting (November 16, 2007)
iSBTc Oncology Biologics Development Primer
iSBTc Hold Successful Annual Meeting - Announces Award Winners (November 16, 2007) >
iSBTc Dinner Symposium Addresses Immune Responses and Stem Cell Transplantation (November 16, 2007)
iSBTc Workshop Examines State of the Science and Barriers to the Clinical Translation
of New Combination Therapies for Cancer (November 16, 2007)
New Research Focuses on IL-24 and Its Role in Wound Healing (October 26, 2007)
Primer Speakers to Address Tumor Immunology and Biological Therapy (October 24, 2007)
Dr. Ernest Borden Receives 2007 Smalley Award (October 15, 2007)
iSBTc Annual Meeting to Showcase Advances in Immunology and Biological Therapy (October 12, 2007)
iSBTc Mini-Symposium Addresses Critical Component for Future Combination Therapies of Cancer (July 24, 2007)
CVCTWG Describes New Clinical Development Paradigm for Cancer Vaccines (January 8, 2007)

2006

Dr. Ronald Levy Accepts 2006 Smalley Award (October 23, 2006)
iSBTc 21st Annual Meeting to be Held October 26 - 29 in Los Angeles, CA. (October 23, 2006)

2005

iSBTc Holds Successful 20th Anniversary Annual Meeting (December 5, 2005)
Dr. Steven A. Rosenberg Accepts Inaugural Smalley Award (October 10, 2005)
iSBTc 20th Anniversary Annual Meeting to be Held November 10 - 13 in Alexandria, VA (October 3, 2005)

2003

iSBTc Announces Presidential Awards and Record Meeting Attendance (November 20, 2003)
New Anti-Cancer Vaccine Development to be Presented at iSBTc meeting (October 21, 2003)
iSBTc to Hold Conference Primer: Tumor Immunology and Biological Therapy (October 16, 2003)
iSBTc to Hold First Consensus Conference on Patient Specific Biologic Therapy for Cancer (October 14, 2003)
New Cancer Drug Development to be Presented at iSBTc Meeting (October 7, 2003)
SBT Changes Name to Reflect Organization's Global Efforts in Cancer Research (February 13, 2003)

2002

Dickerson Presented Presidential Award in Biological Therapy of Cancer (December 17, 2002)
James C. Yang to Present Cancer Study at SBT Meeting in San Diego (October 2002)